OLED — what changed in the latest 10-Q
A section-by-section comparison of OLED's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-10-28 vs the prior 10-Q · 2026-07-30
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +22 | −18 | ~19 | 33 |
| Market risk (Item 3) | No paragraph-level changes | 0 | 0 | 0 | 2 |
| Controls & procedures | Text added/removed | 0 | 0 | ~2 | 0 |
| Legal proceedings | No paragraph-level changes | 0 | 0 | 0 | 2 |
| Risk factors | No material changes reported (points to the 10-K) | — | — | — | — |
| Other information | Text added/removed | +2 | 0 | ~1 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-10-28
Comparison of the Three Months Ended September 30, 2026 and 2025
Our total material sales were $79.7 million for the three months ended September 30, 2026, as compared to $82.6 million for the three months ended September 30, 2025, a decrease of 4% with an increase in unit material volume of 9%. The decrease in material sales was primarily due to changes in custo…
Revenue from royalty and license fees was $75.5 million for the three months ended September 30, 2026 as compared to $53.3 million for the three months ended September 30, 2025, an increase of 42%. The increase in royalty and license fees was primarily the result of a $9.5 million out-of-period adju…
The total cumulative catch-up adjustment recorded to revenue arising from changes in estimates of transaction price, net was a reduction of $3.5 million for the three months ended September 30, 2026 as compared to a net increase of $1.3 million for the three months ended September 30, 2025. For the …
Research and development expenses were $36.3 million for both three months ended September 30, 2026 and 2025.
Text removed vs the prior filing · source: 10-Q · 2026-07-30
Our total material sales were $66.2 million for the three months ended June 30, 2026, as compared to $88.7 million for the three months ended June 30, 2025, a decrease of 25% with a decrease in unit material volume of 11%. The decrease in material sales was primarily due to lower unit material volum…
Revenue from royalty and license fees was $81.2 million for the three months ended June 30, 2026 as compared to $75.7 million for the three months ended June 30, 2025, an increase of 7%. The increase in royalty and license fees was primarily the result of a $16.3 million favorable period-over-period…
The total cumulative catch-up adjustment recorded to revenue arising from changes in estimates of transaction price, net was an increase of $10.1 million for the three months ended June 30, 2026 as compared to a net increase of $655,000 for the three months ended June 30, 2025.
Research and development expenses decreased to $35.0 million for the three months ended June 30, 2026, as compared to $36.4 million for the three months ended June 30, 2025. The decrease in research and development expenses was primarily due to a reduction in stock-based compensation and contract re…
Patent costs decreased to $2.4 million for the three months ended June 30, 2026, as compared to $2.6 million for the three months ended June 30, 2025.
Other information
Text added vs the prior filing · source: 10-Q · 2026-10-28
On October 27, 2026, the Company’s Board of Directors (the “Board”), on the recommendation of its Human Capital Committee (the “HCC”), adopted Amendment 2026-1 to the SERP (“Amendment 2026-1”). Amendment 2026-1 amended the SERP to change the designated retirement age from age 65 to age 62, and to pr…
Also on October 27, 2026, the Board adopted a Senior Management Severance Program (the “SMSP”). Participants in the SERP are not eligible to participate in the SMSP. Thus, the only named executive officer who will participate in the SMSP is Brian Millard, the Company’s Vice President, Chief Financia…
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice